It depends on what you are treating, how the protocol is structured, and whether the peptide comes from a licensed 503A compounding pharmacy or a research supply website
In fact, evidence shows that many Type I and II tears respond well to conservative careparticularly when managed by an experienced physical therapist
We prescribe BPC-157 because the preclinical evidence and clinical experience justify it, not because the human RCT data is complete
Regulatory Status Summary (as of July 29, 2026) Category 2 restricted status: Removed (April 2026) FDA approval: None USP/NF monograph: None 503A Bulks List: PCAC recommended inclusion (July 2324, 2026, nonbinding)
The practical advantage of AOD-9604 over HGH Fragment 176-191 is the safety data
the 2024 AlphaWave stress RCT and the 2025 sleep meta-analysis